Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 193 of 6351
-
A new hope for MDS patients: could this drug cut blood transfusions?
Disease control Not yet recruitingThis study will observe adults with lower-risk myelodysplastic neoplasms (MDS) who have anemia requiring regular red blood cell transfusions and who are prescribed first-line luspatercept as part of routine medical care. The study will follow participants for up to 2 years to und…
Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
Can an immunotherapy combo shrink throat tumors before surgery?
Disease control Not yet recruitingThis is a prospective, single-arm, phase II clinical study aimed to evaluate the efficacy and safety of penpulimab combined with chemotherapy in the treatment of locally advanced hypopharyngeal carcinoma.
Phase 2 • Sponsor: Tang-Du Hospital • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
Less may be more: smaller lung surgery tested against standard for early cancer
Disease control Not yet recruitingSOLID is a multicenter, open-label, randomized, controlled, phase III non-inferiority trial comparing anatomic segmentectomy with lobectomy in patients with deeply located, solid-dominant, clinical stage IA non-small cell lung cancer (NSCLC) measuring \<=2 cm. Eligible participan…
Sponsor: Shanghai Chest Hospital • Aim: Disease control
Last updated Aug 28, 2026 00:00 UTC
-
Adaptive dosing of immunotherapy shows promise for Tough-to-Treat liver cancer
Disease control Recruiting nowThe goal of this clinical trial is to learn if immunotherapy including nivolumab plus ipilimumab is effective and safe in treating hepatocellular carcinoma.
Phase 2 • Sponsor: University of Texas Southwestern Medical Center • Aim: Disease control
Last updated Aug 27, 2026 00:00 UTC
-
Can a drug combo prime the immune system to fight kidney cancer before surgery?
Disease control Not yet recruitingThis prospective, open-label, single-arm Phase 2 study is evaluating toripalimab plus axitinib as induction therapy for adults with newly diagnosed metastatic clear cell renal cell carcinoma whose primary kidney tumor remains in place and whose baseline kidney-tumor core biopsy c…
Phase 2 • Sponsor: Fudan University • Aim: Disease control
Last updated Aug 22, 2026 00:00 UTC
-
Can a new vaccine shield more people from hepatitis a?
Vaccine Recruiting nowThis is a Phase Ⅲ, open-label, single arm design combined with randomized, double-blind, active-controlled design trial to assess the immunogenicity and safety of different specifications of Healive® (the 0.5 mL pediatric dosage and the 1 mL adult dosage). A total of 680 healthy…
Phase 3 • Sponsor: Sinovac Biotech Co., Ltd • Aim: Vaccine
Last updated Aug 30, 2026 00:00 UTC
-
New antibody drugs aim to prevent Catheter-Related blood clots
Disease control Not yet recruitingThis study is researching 2 different experimental drugs called REGN7508 and REGN9933 (called "study drugs"). The study is focused on people who have a tube placed in a vein to receive treatment (called Peripherally Inserted Central Catheter \[PICC\]). Patients with PICCs have a …
Phase 3 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
A painless spleen scan could spot deadly vein bleeding risk without endoscopy
Diagnosis Not yet recruitingEsophageal variceal bleeding is one of the serious and life-threatening complications of chronic liver disease (CLD). Studies have shown that the prevalence of esophageal varices (EV) in patients with liver cirrhosis is about 50%-60%. The annual incidence of variceal bleeding in …
Sponsor: Beijing Friendship Hospital • Aim: Diagnosis
Last updated Aug 09, 2026 00:00 UTC
-
Can a higher transfusion threshold save lives in the operating room?
Disease control Not yet recruitingThe goal of this randomized clinical trial is to address the uncertainty surrounding blood transfusion strategies in the operating room for adult patients undergoing major surgery. The main question it aims to answer is: Does a higher hemoglobin threshold for blood transfusion d…
Sponsor: Ottawa Hospital Research Institute • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
Can MRI-Guided radiation offer a safer way to treat kidney cancer?
Disease control Recruiting nowThe purpose of this study is to investigate the use of an MR-guided linear accelerator to treat early stage renal cancer patients, considered inoperable or in patients declining surgerys. The study will collect efficacy, toxicity, and dosimetry data and assess the degree of impro…
Sponsor: NYU Langone Health • Aim: Disease control
Last updated Aug 23, 2026 00:00 UTC
-
Can a new drug combo shrink advanced colorectal tumors?
Disease control Recruiting nowThis is a multicenter, open-label, dose-escalation/dose-expansion, Phase Ib/II study to evaluate the safety, tolerability, PK characteristics, and preliminary anti-tumor efficacy of HDM2017 combination therapy in participants with advanced CRC. The study is divided into two perio…
Phase 1/2 • Sponsor: Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
Can a daily pill bring back hair in severe alopecia?
Disease control Recruiting nowThis study is a multicenter, randomized, double-blind, placebo-controlled Phase II clinical study designed to evaluate the efficacy and safety of VC005 tablets in subjects with severe alopecia areata (AA).
Phase 2 • Sponsor: Jiangsu vcare pharmaceutical technology co., LTD • Aim: Disease control
Last updated Aug 29, 2026 00:00 UTC
-
Could essential oils tame chemo nausea? a new trial puts aromatherapy to the test
Symptom relief Not yet recruitingThis phase III, multicenter, randomized, open-label trial evaluates whether aromatherapy plus standard antiemetic therapy improves complete response (CR) of CINV compared with standard therapy alone in breast cancer patients receiving highly emetogenic chemotherapy (HEC). Despite…
Phase 3 • Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University • Aim: Symptom relief
Last updated Aug 14, 2026 00:00 UTC
-
New drug aims to stop bleeding in emergency surgeries for blood thinner users
Disease control Recruiting nowThe goal of this clinical trial is to learn if VMX-C001 works to to allow blood clotting control in participants who take FXa Direct Oral Anticoagulants (DOACs) during surgery or other invasive procedures that carry a high risk of bleeding. The main question it aims to answer is:…
Phase 3 • Sponsor: VarmX B.V. • Aim: Disease control
Last updated Aug 23, 2026 00:00 UTC
-
Could a blast of argon plasma wipe out cervical precancer without surgery?
Cure Not yet recruitingThe study aims to show that treatment with LtAPD works better than a sham treatment or simply monitoring the condition closely without active treatment ("active surveillance"), in achieving complete healing of a tissue abnormality on the cervix called CIN 2, after 6 months. This …
Sponsor: University Hospital Tuebingen • Aim: Cure
Last updated Aug 05, 2026 00:00 UTC
-
Could a simple scan replace invasive heart imaging before bypass surgery?
Disease control Recruiting nowThe goal of this clinical trial is to find out if using a non-invasive heart scan (called coronary computed tomography angiography, or CCTA) to plan coronary artery bypass grafting (CABG) works as well as the standard invasive approach (called coronary angiography, or CAG) for pe…
Sponsor: Ruijin Hospital • Aim: Disease control
Last updated Aug 21, 2026 00:00 UTC
-
Group emotion regulation therapy put to the test for teen self-harm
Disease control Not yet recruitingAdolescent non-suicidal self-injury (NSSI) is common, strongly associated with psychiatric comorbidity and an increased risk of future suicide attempt. Although interventions targeting emotion regulation have been shown to reduce NSSI in both adults and adolescents few, are avail…
Sponsor: Karolinska Institutet • Aim: Disease control
Last updated Aug 20, 2026 00:00 UTC
-
Can a new drug combo outsmart resistant lung cancer?
Disease control Recruiting nowThis is a multi-center, open label, Phase 1b study of NXP900 in combination with lorlatinib in subjects with advanced, ALK-positive non-small cell lung cancer (NSCLC)
Phase 1 • Sponsor: Nuvectis Pharma, Inc. • Aim: Disease control
Last updated Aug 27, 2026 00:00 UTC
-
Weekly shot aims to tame dangerous fat levels in the blood
Disease control Not yet recruitingThis is a multicenter, randomized, double-blind, placebo-controlled Phase 3 clinical trial to assess the efficacy and safety of weekly subcutaneous DR10624 injection in adult patients with severe hypertriglyceridemia (sHTG). Eligible participants have persistently elevated fastin…
Phase 3 • Sponsor: Zhejiang Doer Biologics Co., Ltd. • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
Can a targeted drug boost Chemotherapy's power against a rare lymphoma?
Disease control Not yet recruitingThis is a prospective, multicenter, open-label, single-arm, phase II clinical study to evaluate the safety and efficacy of golidocitinib in combination with an anthracycline-based regimen as first-line treatment for patients with previously untreated nodal T-follicular helper (TF…
Phase 2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC